Pragmatic Evaluation of an Improvement Program for People Living With Modifiable High-Risk COPD Versus Usual Care: Protocols for the Cluster Randomized PREVAIL Trial
Hickman, K., Tarabichi, Y., Dickens, A. P., Pullen, R., Kerr, M., Couper, A., Evans, A., Gatenby, J., Alves, L., Ariti, C., Bafadhel, M., Carter, V., Chalmers, J., Chen, R., Devereux, G., Drummond, M. B., Gibson, J. M., Halpin, D. M. G., Han, M., Hanania, N. A., Hurst, J. R., Kaplan, A., Kostikas, K., Make, B., Mapel, D., Marshall, J., Martinez, F., Meldrum, C., van Melle, M., Miravitlles, M., Morris, T., Mullerova, H., Murray, R., Muro, S., Nordon, C., Ohar, J., Pace, W., Pollack, M., Quint, J. K., Sharma, A., Singh, D., Singh, M., Trudo, F., Williams, D., Wilkinson, T., Winders, T., Price, D.
Prevention of cardiovascular and other systemic adverse outcomes in patients with asthma treated with biologics
Sadatsafavi, M., Tran, T. N., Scelo, G., Tsai, M., Busby, J., Emmanuel, B., Heaney, L. G., Jenkins, C., Hoyte, F. L., Canonica, G. W., Katial, R., Heffler, E., Wang, E., Puggioni, F., Wechsler, M. E., Ardusso, L. R. F., Maspero, J. F., Sivori, M., Emmas, C., Menzies-Gow, A., Stjepanovic, N., Bosnic-Anticevich, S. Z., Cochrane,, B., Denton, E., Gibson, P. G., Hew, M., Middleton, P. G., Peters, M. J., Brusselle, G., Louis, R., Schleich, F., Christoff, G. C., Popov, T. A., Bergeron, C., Bhutani, M., Chapman, K. R., Côté, A., Couillard, S., Dorscheid, D. R., Jiménez-Maldonado, L., Solarte, I., Torres-Duque, C. A., Hansen, S., Porsbjerg, C. M., Suppli Ulrik, C., Altraja, A., Bourdin, A., Exarchos, K. P., Gogali, A., Kostikas, K., Makris, M. P., Papaioannou, A. I., Mitchell, P., Iwanaga, T., Nagano, T., Tohda, Y., Al-Ahmad, M. S., Larenas-Linnemann, D., Bøgvald Aarli, B., Kuna, P., Loureiro, C. C., Al-Lehebi, R., Bulkhi, A. A., Chen, W., Juang, Y. R., Koh, M. S., Liu, A., Rhee, C. K., Cosio, B. G., Perez de Llano, L., Perng, D. W., Sheu, C., Wang, H., Mahboub, B., Salameh, L., Jackson, D. J., Patel, P. H., Pfeffer, P. E., Lugogo, N., Pleasants, R. A., Beastall, A., Bulathsinhala, L., Carter, V., Eleangovan, N., Fletton, K., Townend, J., Murray, R. B., Price, D., ISAR SOLAR II Working Group
American Journal of Respiratory and Critical Care Medicine
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT
Devereux, G., Cotton, S., Nath, M., McMeekin, N., Campbell, K., Chaudhuri, R., Choudhury, G., De Soyza, A., Fielding, S., Gompertz, S., Haughney, J., Lee, A., MacLennan, G., Morice, A., Norrie, J., Price, D., Short, P., Vestbo, J., Walker, P., Wedzicha, J., Wilson, A., Wu, O., Lipworth, B.
Health Technology Assessment, vol. 29, no. 17, pp. i-xvi, 1-97
Impact of Biologic Initiation on New-Onset of Corticosteroid-Related Adverse Effects in Patients with Severe Asthma
Price, D., Emmanuel, B., Scelo, G., Altraja, A., Cochrane,, B., Chen, W., Koh, M. S., Solarte Rodriguez, I., Tsai, M., Suppli Ulrik, C., Bergeron, C., Christoff, G. C., Gogali, A., Hansen, S., Hew, M., Katial, R., Perez de Llano, L., Puggioni, F., Bulkhi, A. A., Côté, A., Emmas, C., Heaney, L. G., Jiménez-Maldonado, L., Mitchell, P., Papaioannou, A. I., Schleich, F., Sheu, C., Maspero, J. F., Gibson, P. G., Torres-Duque, C. A., Porsbjerg, C. M., Bourdin, A., Canonica, G. W., Heffler, E., Iwanaga, T., Larenas-Linnemann, D., Kuna, P., Al-Lehebi, R., Rhee, C. K., Cosio, B. G., Perng, D. W., Mahboub, B., Busby, J., Jackson, D. J., Patel, P. H., Pfeffer, P. E., Fletton, K., Murray, R. B., Townend, J., Tran, T. N., ISAR SOLAR II Working Group
American Thoracic Society Conference 2025, pp. A5552
Offering Digital Adherence Support Improves Clinical Outcomes for High-risk Chronic Obstructive Pulmonary Disease (COPD) Patients with Poor Adherence to Inhaled Therapy
Price, D., Dickens, A. P., Henley, W., Skinner, D., Pinnock, H., van Boven, J. F., Roche, N., Kostikas, K., Beeh, K. M., Usmani, O., Clark, A., Chalmers, J. D., Kaplan, A., Carter, V., Smith, U., Burnett-Kirton, Z., White, S. M., Davis, S. R., Hannan, N., Igwe, F., Mastoridis, P., Mezzi, K., Pfister, P., Halpin, D. M.
Patterns of care in the management of high-risk COPD in Australia (2015–2019): observational study for the CONQUEST quality improvement program
Jenkins, C., Dickens, A. P., Evans, A., Le Cheng, P., Heraud, F., Hancock, K., Sharma, A., Cochrane,, B., Roussos, A., Le Lievre, C. E., Blakey, J. D., Bosnic-Anticevich, S., Carter, V., Catanzariti, A., Ghisla, C., Hew, M., Ko, B., Le, T., Leong, P., McDonald, V., Lau, C. M., Perret, J., Pullen, R., Ranasinghe, K., Soriano, J. B., Stewart, D., van Melle, M., Wiseman, R., Price, D.
The Lancet Regional Health - Western Pacific, vol. 58, 101555
The BETRI study: preliminary information on characteristics of patients with asthma or asthma-COPD overlap treated with Medium-Strength Inhaled Corticosteroid / Long-Acting Beta-Agonists (ICS/LABA) and switching to High-Strength ICS/LABA or Medium-Strength Beclomethasone /Formoterol /Glycopyrronium (BDP/FF/G)
Piraino, A., Brusselle, G., Grainge, C., Roche, N., Gayle, A., Carter, V., Price, D., Di Palma, L., Singh, D.